Pasireotide

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 734 publications

Resistant prolactinomas.

Resistant prolactinomas.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: March 28, 2026

Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches.

Developments in Pharmacotherapy for Acromegaly: Current and Emerging Approaches.

Journal: Drugs

Published: January 30, 2026

Current Treatment Landscape of Acromegaly.

Current Treatment Landscape of Acromegaly.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 26, 2026

Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment.

Cost-effectiveness of pasireotide long-acting release in acromegaly: a systematic literature review and methodology assessment.

Journal: Journal of medical economics

Published: January 10, 2026

Efficacy and Safety of Pharmacologic Therapies in Acromegaly: A Systematic Literature Review and Network Meta-Analysis.

Efficacy and Safety of Pharmacologic Therapies in Acromegaly: A Systematic Literature Review and Network Meta-Analysis.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 23, 2025

Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.

Anti-secretory and anti-proliferative actions of next-generation dual subtype 2 and 5 somatostatin receptor ligands in neuroendocrine tumor models.

Journal: Frontiers in oncology

Published: December 15, 2025

Early hypocortisolism with persistent remission following osilodrostat in a patient with long-standing Cushing disease.

Early hypocortisolism with persistent remission following osilodrostat in a patient with long-standing Cushing disease.

Journal: JCEM case reports

Published: December 02, 2025

Case Report: Paradoxical responses to pasireotide in a patient with a silent corticotroph adenoma that transformed into an ACTH-secreting adenoma.

Case Report: Paradoxical responses to pasireotide in a patient with a silent corticotroph adenoma that transformed into an ACTH-secreting adenoma.

Journal: Frontiers in oncology

Published: November 09, 2025

Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease.

Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease.

Journal: Investigative ophthalmology & visual science

Published: November 07, 2025

Five-year survival outcomes following perioperative hydrocortisone versus pasireotide in patients with high risk of pancreatic fistula: Secondary analysis of the HYPAR randomized clinical trial.

Five-year survival outcomes following perioperative hydrocortisone versus pasireotide in patients with high risk of pancreatic fistula: Secondary analysis of the HYPAR randomized clinical trial.

Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society

Published: October 27, 2025

Somatostatin and its analogs in the management of postoperative pancreatic fistulas: A comprehensive review.

Somatostatin and its analogs in the management of postoperative pancreatic fistulas: A comprehensive review.

Journal: World journal of gastrointestinal surgery

Published: October 16, 2025

Histological Evidence of familial GH-PitNET Associated with Germline MAX Mutation.

Histological Evidence of familial GH-PitNET Associated with Germline MAX Mutation.

Journal: European journal of endocrinology

Published: September 30, 2025

Showing 1-12 of 734

Last Updated: 04/28/2026